Citation: Ld. Penn et al., LC/MS/MS quantitation of an anti-cancer drug in human plasma using a solid-phase extraction workstation: application to population pharmacokinetics, J PHARM B, 25(3-4), 2001, pp. 569-576
Authors:
Olson, SC
Bockbrader, H
Boyd, RA
Cook, J
Koup, JR
Lalonde, RL
Siedlik, PH
Powell, JR
Citation: Sc. Olson et al., Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process - Experience at Parke-Davis, CLIN PHARMA, 38(5), 2000, pp. 449-459
Citation: Rh. Stern et al., Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor, J CLIN PHAR, 40(6), 2000, pp. 616-623
Authors:
Suggs, WD
Olson, SC
Madnani, D
Patel, S
Veith, FJ
Citation: Wd. Suggs et al., Antisense oligonucleotides to c-fos and c-jun inhibit intimal thickening in a rat vein graft model (vol 126, pg 443, 1999), SURGERY, 127(2), 2000, pp. 135-135
Authors:
Suggs, WD
Olson, SC
Mandani, D
Patel, S
Veith, FJ
Citation: Wd. Suggs et al., Antisense oligonucleotides to c-fos and c-jun inhibit intimal thickening in a rat vein graft model, SURGERY, 126(2), 1999, pp. 443-449